| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | 0.14 | 0.5 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |